As of Oct 26
| -0.10 / -3.57%|
The 1 analysts offering 12-month price forecasts for Adamis Pharmaceuticals Corp have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +270.37% increase from the last price of 2.70.
The current consensus among 1 polled investment analysts is to Buy stock in Adamis Pharmaceuticals Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.